Creafuse Powder Recalled for DMAA, Illegal Stimulant

September 16, 2013 — The U.S. Food and Drug Administration (FDA) and Ge Pharma, LLC have issued a recall for Creafuse Powder because it contains DMAA, an illegal stimulant drug also known as 1,3-dimethylamylamine.

Products in the Creafuse Powder recall include:

  • Creafuse Powder Grape Lot# GE4568
  • Creafuse Powder Fruit Punch Lot #GE4570

The products were sold nationwide via telephone and email. They are packaged in a white, 600-gram container with an expiration date of February 2015. Ge Pharma requests that customers should stop using the product, report adverse events to a doctor and the FDA, and contact the company for a refund.

According to the FDA:

“The FDA has warned that DMAA is potentially dangerous to health. Ingestion of DMAA can elevate blood pressure and lead to cardiovascular problems. A number of adverse effects associated with DMAA containing dietary supplements have been reported to the FDA.”

The FDA has been cracking down on DMAA supplements since mid-2012. The enforcement began with a series of warning letters to 10 manufacturers. Most of the manufacturers stopped selling DMAA or reformulated their products.

However, the largest manufacturer, USPLabs, argued that the stimulant was an all-natural extract of the geranium plant. The FDA disagreed. In July 2013, more than $8 million worth of Jack3D and OxyElite Pro were destroyed by USPLabs.

Need a Texas Creafuse Powder Lawyer?

Collen A. Clark is a true advocate for his clients and is passionate about helping Texans that have been injured or wronged.

Collen’s amazing success in the courtroom and well known dedication to his clients has earned him the recognition of his peers as one of The Top Trial Lawyers in Texas.”

The Clark Firm has assembled a team of trial lawyers with more than 100 years experience, participation in over 600 jury trials and $60 million in verdicts and/or settlements. Please use the form below to contact our Texas Creafuse Powder lawyers for a free lawsuit review.